#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3312	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2536	386.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1969	1969	T	453	T,C,G	396,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3312	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2536	386.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1703	1703	C	493	C,T	414,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3955	402.7	0	.	n	.	0	T695C	SNP	695	695	T	1216	1216	C	387	C,T	322,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3955	402.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2492	2492	C	533	C,T	455,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3955	402.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2566	2566	A	566	A	481	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5320	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3955	402.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3118	3118	C	492	C,A	402,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	546	folP	855	855	99.88	folP.l15.c4.ctg.1	1966	83.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1234	1236	AGC	143;145;145	A;G;C	116;120;118	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1164	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3774	92.4	0	.	p	.	0	G95A	NONSYN	283	285	GGC	773	775	GCC	102;101;101	G,A;CCAC,CC;C	89,1;91,1;94	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1164	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3774	92.4	1	SNP	p	S91F	1	.	.	271	273	TTC	761	763	TTC	103;104;102	T;T;C	88;89;88	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	458	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1655	82.5	1	SNP	p	G45D	1	.	.	133	135	GAC	575	577	GAC	127;127;127	G;A,G;C	111;114,1;113	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	304	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1408	64.8	0	.	n	.	0	A197.	DEL	197	197	A	774	774	A	122	A	108	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1216	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3364	108.1	1	SNP	p	D86N	0	.	.	256	258	GAC	729	731	GAC	135;135;135	G;A;C	118;115;119	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1216	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3364	108.1	1	SNP	p	R87W	0	.	.	259	261	CGT	732	734	CGT	134;134;134	C;G;T	118;118;118	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1216	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3364	108.1	1	SNP	p	S87R	1	.	.	259	261	CGT	732	734	CGT	134;134;134	C;G;T	118;118;118	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1216	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3364	108.1	1	SNP	p	R87I	0	.	.	259	261	CGT	732	734	CGT	134;134;134	C;G;T	118;118;118	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	1216	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3364	108.1	1	SNP	p	S88P	0	.	.	262	264	TCC	735	737	TCC	134;134;135	T;C;C,T	112;119;119,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1006	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3167	95.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1853	1855	GGC	130;129;129	G;G;C	108;109;106	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1507	1509	GCA	119;120;120	G;C;A,C	101;101;103,1	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1510	1512	ATC	120;120;120	A;T;C,G	101;99;104,1	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1522	1524	GTG	124;123;123	G,A;T,C;G,C	104,1;99,1;104,1	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1522	1524	GTG	124;123;123	G,A;T,C;G,C	104,1;99,1;104,1	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2026	2028	ACC	86;86;86	A;C,A;C	73;72,2;75	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2080	2082	GCG	86;84;86	G;C,G,T;G	77;70,2,1;75	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2080	2082	GCG	86;84;86	G;C,G,T;G	77;70,2,1;75	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2203	2205	GGC	96;95;94	G;G;C	79;78;75	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2212	2214	GGC	94;94;94	G;G;C	77;77;78	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	800	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2843	84.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2230	2232	CCG	97;97;98	C;C;G	76;81;78	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1212	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3526	103.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1780	1782	CCG	108;108;108	C;C;G	91;88;92	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	554	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2395	69.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	677	679	GGC	96;95;94	G;G;C	82;80;82	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	554	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2395	69.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	859	859	C	90	C	74	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	635	637	GAA	138;138;138	G;A;A,G	121;118;118,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	923	925	GAT	153;150;150	G;A;T	126;125;125	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1046	1048	TCA	143;144;144	T;C;A	116;116;114	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	0	.	p	.	0	N213S	NONSYN	637	639	AAT	1160	1162	AGT	146;147;147	A;G;T	128;128;127	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	0	.	p	.	0	F215L	NONSYN	643	645	TTT	1166	1168	CTT	145;144;146	C;T;T	131;123;129	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1175	1177	ATC	146;146;149	A;T;C,A	131;127;126,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	1	SNP	p	G120K	1	.	.	358	360	AAG	881	883	AAG	149;151;152	A;A,C;G	130;137,1;134	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	1	SNP	p	D121N	0	.	.	361	363	GAC	884	886	GAC	153;153;153	G,T;A;C	136,1;135;139	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	720	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	2062	103.7	1	SNP	p	A121D	1	.	.	361	363	GAC	884	886	GAC	153;153;153	G,T;A;C	136,1;135;139	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2106	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5384	117.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	366	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1405	77.7	1	SNP	p	V57M	1	.	.	169	171	ATG	658	660	ATG	129;130;131	A;T;G	109;110;112	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
